MECHELEN, Belgium – Cargill is in discussions with Royal DSM, a global life sciences and materials company, about a possible sale of Cargill’s cultures and enzymes business.
Cargill’s cultures and enzymes operation manufactures items for the dairy and meat industries. It also forms part of the company’s global texturizing business and employs roughly 200 people. The cultures and enzymes business has production facilities in Wisconsin and La Ferte-Sous-Jouarre, France, according to Cargill.
“The proposed sale is in line with Cargill’s strategy to refocus its texturizing business and concentrate on product lines that are adjacent to the company’s core activities and where it can be a leading or relevant player in the marketplace,” the company said in a statement.
The companies are in the information gathering and consultation phase with employee representatives who will give their input on the proposed sale, Cargill said.